Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Volcano Defies Downward Trend In Imaging Market With 24% Q1 Sales Growth

This article was originally published in The Gray Sheet

Executive Summary

Despite a scarcity of capital available to hospitals to buy imaging equipment, Volcano placed 74% more intravascular ultrasound (IVUS) consoles in the first quarter of 2009 than it did in the same quarter a year ago, the company reported May 7

You may also be interested in...



Sales & Earnings In Brief

Hansen Medical: Firm reported a 43% drop in second-quarter revenues Aug. 4 -- to $3.3 million from $5.8 million in the same quarter of 2008 -- with lower-than-expected sales of the Sensei robotic catheter system. Hansen shipped six Sensei systems in the quarter, but only recognized revenue on three. Firm anticipates FDA clearance of an enhanced Sensei platform and Artisan catheter in the third quarter, and hopes to launch a smaller, more flexible ablation catheter in Europe in early 2010. The firm is working on a new platform for complex vascular procedures, but CEO Fred Moll says a clinical trial is not likely to begin before 2010 (1"The Gray Sheet" Dec. 8, 2008)

Sales & Earnings In Brief

Hansen Medical: Firm reported a 43% drop in second-quarter revenues Aug. 4 -- to $3.3 million from $5.8 million in the same quarter of 2008 -- with lower-than-expected sales of the Sensei robotic catheter system. Hansen shipped six Sensei systems in the quarter, but only recognized revenue on three. Firm anticipates FDA clearance of an enhanced Sensei platform and Artisan catheter in the third quarter, and hopes to launch a smaller, more flexible ablation catheter in Europe in early 2010. The firm is working on a new platform for complex vascular procedures, but CEO Fred Moll says a clinical trial is not likely to begin before 2010 (1"The Gray Sheet" Dec. 8, 2008)

No Sign Of Capital Equipment Turn-Around In Philips’ Q1 Sales

Declining sales of imaging and patient monitoring systems were a significant drag on Philips' health care business in the first quarter of 2009, the firm reported April 14

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel